36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
The use of procalcitonin testing for sepsis management is highest in the US
The only definitive way to diagnose and stage lung cancers is through biopsies
The global VR market to grow at a compound annual growth rate of 13% from $7 billion in 2018 to $28 billion in 2030.
The Coalition for Epidemic Preparedness Innovations (CEPI) has recently partnered with the consortium of India-based Bharat Biotech, University of Sydney and ExcellGene to develop “variantproof” COVID-19 vaccine.
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
There is also a growing interest in whole generation sequencing (WGS)
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
